Adipose tissue and atherothrombosis

被引：46

作者：

Alessi, MC

Lijnen, HR

Bastelica, D

Juhan-Vague, I

机构：

[1] Univ Mediterranee, Fac Med Timone, UMR 626, INSERM,Lab Hematol, F-13385 Marseille 5, France

[2] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium

来源：

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 2003年 / 33卷 / 5-6期

关键词：

obesity; leptin; adiponectin; inflammation; PAI-1; thrombosis; vascular;

D O I：

10.1159/000083816

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Obesity is associated with increased cardiovascular mortality and morbidity mainly through insulin resistance. Dysregulation of protein secretion by adipose tissue is involved in obesity-related diseases. Adipose tissue contributes to create a subinflammatory status which could explain the disturbances in the haemostatic and fibrinolytic systems observed in obesity. Elevated plasma levels of PAI-1 demonstrated the strongest association with the degree of insulin resistance and could be an underlying mechanism for the thrombotic tendency and the progression of atherothrombosis during obesity. The effect of PAI-1 was examined on adipose tissue growth in several mouse models as well as on adipocyte differentiation in vitro. Most of the data indicate that PAI-1 can effectively modulate weight gain and may be a potential therapeutic target for controlling cardiovascular morbidity in obese subjects. Copyright (C) 2004 S. Karger AG, Basel.

引用

收藏

页码：290 / 297

页数：8

相关论文

共 106 条

[1] Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation [J].

Alessi, MC ;

Bastelica, D ;

Mavri, A ;

Morange, P ;

Berthet, B ;

Grino, M ;

Juhan-Vague, I .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) :1262-1268

[2] Fat cell function and fibrinolysis [J].

Alessi, MC ;

Morange, P ;

Juhan-Vague, I .

HORMONE AND METABOLIC RESEARCH, 2000, 32 (11-12) :504-508

[3] Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease [J].

Anand, SS ;

Yi, QL ;

Gerstein, H ;

Lonn, E ;

Jacobs, R ;

Vuksan, V ;

Teo, K ;

Davis, B ;

Montague, P ;

Yusuf, S .

CIRCULATION, 2003, 108 (04) :420-425

[4]

Bastelica D, 2002, THROMB HAEMOSTASIS, V88, P481

[5] Expression of leptin receptor isoforms in rat brain microvessels [J].

Bjorbæk, C ;

Elmquist, JK ;

Michl, P ;

Ahima, RS ;

van Bueren, A ;

McCall, AL ;

Flier, JS .

ENDOCRINOLOGY, 1998, 139 (08) :3485-3491

[6] Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis [J].

Bråkenhielm, E ;

Veitonmäki, N ;

Cao, RH ;

Kihara, S ;

Matsuzawa, YJ ;

Zhivotovsky, B ;

Funahashi, T ;

Cao, YH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (08) :2476-2481

[7] Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans [J].

Brown, NJ ;

Agirbasli, M ;

Vaughan, DE .

HYPERTENSION, 1999, 34 (02) :285-290

[8] Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α.: Effect of weight loss in obese men [J].

Bruun, JM ;

Verdich, C ;

Toubro, S ;

Astrup, A ;

Richelsen, B .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (05) :535-542

[9] Impairment of early fibrinolytic activation after PTCA: a mechanism for restenosis-related clinical recurrence? [J].

Capanni, M ;

Antonucci, E ;

Chiarugi, L ;

Boddi, V ;

Abbate, R ;

Prisco, D ;

Giglioli, C ;

Dabizzi, RP ;

Margheri, M ;

Simonetti, I ;

Gensini, GF .

FIBRINOLYSIS & PROTEOLYSIS, 1999, 13 (01) :8-14

[10] Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation - A gene targeting and gene transfer study in mice [J].

Carmeliet, P ;

Moons, L ;

Lijnen, HR ;

Janssens, S ;

Lupu, F ;

Collen, D ;

Gerard, RD .

CIRCULATION, 1997, 96 (09) :3180-3191

← 1 2 3 4 5 6 7 8 9 10 →